* The Oncology Institute press release [https://seekingalpha.com/pr/20200186-the-oncology-institute-reports-second-quarter-2025-financial-results-and-reaffirms-full-year] (NASDAQ:TOI [https://seekingalpha.com/symbol/TOI]): Q2 GAAP EPS of -$0.15 misses by $0.03.
* Revenue of $119.8M (+21.0% Y/Y) beats by $6.63M.
*
2025 Guidance
Revenue
$460 to $480 million
Gross Profit
$73 to $82 million
Adjusted EBITDA
$(8) to $(17) million
Free Cash Flow
$(12) to $(21) million
MORE ON THE ONCOLOGY INSTITUTE
* The Oncology Institute, Inc. (TOI) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4813378-the-oncology-institute-inc-toi-q2-2025-earnings-call-transcript]
* The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41% [https://seekingalpha.com/news/4485100-the-oncology-institute-anticipates-q4-adjusted-ebitda-positivity-as-pharmacy-revenue-grows-41]
* Seeking Alpha’s Quant Rating on The Oncology Institute [https://seekingalpha.com/symbol/TOI/ratings/quant-ratings]
* Historical earnings data for The Oncology Institute [https://seekingalpha.com/symbol/TOI/earnings]
* Financial information for The Oncology Institute [https://seekingalpha.com/symbol/TOI/income-statement]
The Oncology Institute GAAP EPS of -$0.15 misses by $0.03, revenue of $119.8M beats by $6.63M
Published 2 months ago
Aug 14, 2025 at 11:13 AM
Positive
Auto